Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,381
Closed -$159K 355
2023
Q4
$159K Sell
10,381
-5,000
-33% -$69.9K 0.06% 228
2023
Q3
$226K Buy
+15,381
New +$240K 0.1% 123
2020
Q1
Sell
-14,405
Closed -$347K 234
2019
Q4
$347K Buy
+14,405
New +$329K 0.27% 126

Other funds holding TBI

Aristides Capital's TBI Position: Q1 2024 in Review

Aristides Capital sold out of Trueblue (TBI) in Q1 2024, closing a stake of 10,381 shares — an estimated $159K sold.

Aristides Capital first reported a position in TBI in Q4 2019 and held it in 3 quarters. The position peaked at $347K in Q4 2019. 137 funds tracked by Wall St. Rank hold TBI as of Q1 2024.

  • Aristides Capital reported no remaining Trueblue position as of Q1 2024 after selling out during the quarter.
  • Aristides Capital sold 10,381 Trueblue shares in Q1 2024, an estimated $159K.
  • Aristides Capital first reported a position in Trueblue in Q4 2019 and held it in 3 quarters.
  • Aristides Capital's Trueblue position peaked at $347K in Q4 2019.
  • 137 funds tracked by Wall St. Rank held Trueblue as of Q1 2024.

Based on Aristides Capital's 13F filing for Q1 2024, filed 15 May 2024.